Advertisement

Table of Contents

November 03, 2016; 128 (18)

INSIDE BLOOD COMMENTARIES

  • BCR inhibitor failure in CLL: an unmet need
    Nitin Jain and Susan O’Brien
  • Gene therapy simplified
    Jiaqiang Ren and David F. Stroncek
  • Down for the count in acute myeloid leukemia
    Aaron D. Goldberg and Martin S. Tallman

CLINICAL TRIALS AND OBSERVATIONS

  • Outcomes of CLL patients treated with sequential kinase inhibitor therapy: a real world experience
    Anthony R. Mato, Chadi Nabhan, Paul M. Barr, Chaitra S. Ujjani, Brian T. Hill, Nicole Lamanna, Alan P. Skarbnik, Christina Howlett, Jeffrey J. Pu, Alison R. Sehgal, Lauren E. Strelec, Alexandra Vandegrift, Danielle M. Fitzpatrick, Clive S. Zent, Tatyana Feldman, Andre Goy, David F. Claxton, Spencer Henick Bachow, Gurbakhash Kaur, Jakub Svoboda, Sunita Dwivedy Nasta, David Porter, Daniel J. Landsburg, Stephen J. Schuster, Bruce D. Cheson, Pavel Kiselev and Andrew M. Evens

GENE THERAPY

IMMUNOBIOLOGY

  • C1q and HMGB1 reciprocally regulate human macrophage polarization
    Myoungsun Son, Amit Porat, Mingzhu He, Jolien Suurmond, Frances Santiago-Schwarz, Ulf Andersson, Thomas R. Coleman, Bruce T. Volpe, Kevin J. Tracey, Yousef Al-Abed and Betty Diamond

LYMPHOID NEOPLASIA

MYELOID NEOPLASIA

LETTERS TO BLOOD

BLOOD WORK